Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
11 Mar, 26
New guidelines on pulmonary embolism (PE) offer evidence based recommendations for evaluating, managing, and following up adults with acute PE. Endorsed by eight societies, it stresses multidisciplinary care across emergency, inpatient, & outpatient settings.
26 Feb, 26
ADA 2026 outlines the standards for obesity pharmacotherapy. It recommends combining person-centered medication with lifestyle changes for adults with obesity. It details weight-loss targets and drug benefits for comorbidities
10 Mar, 26
Diabetes Res Clin Pr...
6 Mar, 26
Cardiovasc Diabetol.
- In 6,847 metabolic dysfunction-associated steatotic liver disease (MASLD) patients (median follow-up 8.8 yrs), 19.6% died (6.5% CV, 1.3% diabetes)
- Higher estimated glucose disposal rate (eGDR) was linked to reduced all-cause (HR=0.94, P < 0.001), CV (HR=0.90, P < 0.001), & diabetes mortality (HR=0.70, P < 0.001)
- ROC AUCs: 0.606, 0.631, 0.729 respectively, eGDR shows prognostic relevance in MASLD.
5 Mar, 26
Mov Disord.
- As per a long-term follow-up study of 15.7 years, higher long term exposure to air pollutants like fine particulate matter (PM2.5), nitrogen dioxide, and black carbon increased Parkinson’s disease risk (hazard ratios per interquartile range were 1.05, 1.03, 1.04, resp.)
- Warm season ozone showed a slight inverse association (HR 0.98)
- Findings supported that air pollution was a risk factor for Parkinson’s disease.
4 Mar, 26
BMJ Open Res Clin.
- As per the analysis of 2016–2021 NIS data of adults with T1DM hospitalized for DKA, sex–age interactions influenced outcomes
- Women had lower AKI odds (aOR 0.56, 0.71, 0.79 across age groups) but higher sepsis odds (aOR 1.66, 1.31, 1.17; all p<0.05)
- Mortality benefit for women was limited to ages 18–44 (aOR 0.72)
- COVID-19 years saw mortality rise across all groups, most in young men (from 0.48% to 0.89%)
2 Mar, 26
Featured

6 Mar, 26

4 Mar, 26

25 Feb, 26
















